ABK Biomedical and COR Development Unveil New Manufacturing Facility for Cancer Treatment in Missouri ABK Biomedical and COR Development have announced their partnership to create a state-of-the-art manufacturing site in Ashland, Missouri, focusing on cancer treatment innovations.

ABK Biomedical and COR Development Unveil New Manufacturing Facility for Cancer Treatment in Missouri #United_States #Ashland #ABK_Biomedical #Eye90_microspheres #COR_Development

ABK Biomedical Concludes Patient Enrollment in Pivotal ROUTE90 Study for Liver Cancer Treatment ABK Biomedical has finalized patient enrollment in the ROUTE90 study. This pivotal clinical trial evaluates the Eye90 microspheres, a potential breakthrough in liver cancer treatment.

ABK Biomedical Concludes Patient Enrollment in Pivotal ROUTE90 Study for Liver Cancer Treatment #Canada #Halifax #ABK_Biomedical #Eye90_microspheres #ROUTE90